ストックスクリーナーアプリを入手
1.35
7.88%
-0.11
アフターアワーズ：
1.39
0.04
+2.96%
前日終値:
$1.46
開ける：
$1.46
24時間の取引高:
648.80K
Relative Volume:
0.09
時価総額：
$11.52M
収益：
$1.78M
当期純損益:
$-58.35M
株価収益率:
-0.8232
EPS:
-1.64
ネットキャッシュフロー:
$-56.66M
1週間 パフォーマンス:
-31.03%
1か月 パフォーマンス:
+78.81%
6か月 パフォーマンス:
-57.97%
1年 パフォーマンス:
+236.25%
1日の値動き範囲:
$1.31
$1.5568
1週間の範囲:
$1.31
$2.00
52週間の値動き範囲:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
XAIR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
1.35 | 12.46M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | D. Boral Capital | Buy |
| 2024-06-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-07-28 | 開始されました | Piper Sandler | Overweight |
| 2023-06-15 | 開始されました | BTIG Research | Buy |
| 2021-04-28 | 開始されました | Truist | Buy |
| 2019-10-22 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Beyond Air Inc (XAIR) 最新ニュース
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - The Manila Times
Beyond Air CEO lines up two investor conference appearances - Stock Titan
Beyond Air, Inc. to Report Q3 Fiscal 2025 Financial Results on February 13, 2026 - Quiver Quantitative
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast - The Manila Times
Merger Talk: Will Beyond Air Inc stock benefit from M ADip Buying & High Accuracy Investment Signals - baoquankhu1.vn
Beyond Air Announces $5 Million Private Placement Financing - TipRanks
Short Squeeze: Will Beyond Air Inc stock benefit from M AMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
Can Beyond Air Inc continue delivering strong returnsJuly 2025 Technicals & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Beyond Air (XAIR) Analyst Rating Maintained as Buy at $11.00 by D. Boral Capital | XAIR Stock News - GuruFocus
Exit Recap: Is Beyond Air Inc showing insider buyingTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Beyond Air Signs Multiple Material Agreements - TradingView
Published on: 2026-01-20 07:10:21 - baoquankhu1.vn
Buybacks Report: Is NRXP in a consolidation phaseEarnings Performance Report & Free Verified High Yield Trade Plans - baoquankhu1.vn
CEO Change: Does Beyond Air Inc have a competitive edgeQuarterly Market Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update - Defense World
Analyst Downgrade: Is Beyond Air Inc stock a buy or sellJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
XAIR: Second-generation nitric oxide device and global expansion set to accelerate growth - TradingView — Track All Markets
Market Review: Does Trump Media Technology Group Corp Equity Warrant have a sustainable dividend2025 Price Momentum & Weekly High Conviction Ideas - baoquankhu1.vn
NY-based Beyond Air announces USD 5M private placement - Medical Buyer
Beyond Air, Inc. Announces Sale of NeuroNOS Stake to XTL Biopharmaceuticals - TradingView
Beyond Air’s Nitric Oxide Bet Faces Cash Burn And Dilution - Finimize
Medical Stocks To Watch Now – January 13th - Defense World
Beyond Air secures $5 million in private placement financing By Investing.com - Investing.com Nigeria
Small Cap Stocks To Research – January 13th - Defense World
Penny Stocks To Follow Now – January 13th - Defense World
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Beyond Air, Inc. announced that it expects to receive $5 million in funding - marketscreener.com
XAIR Stock Soars Amid Strategic Market Moves and Financial Adjustments - StocksToTrade
Beyond Air (XAIR) Secures $5M Through Private Placement Deal - GuruFocus
Title: Beyond Air Inc. Navigates Market Dynamics Amid Strategic Announcements - timothysykes.com
Beyond Air secures $5 million in private placement financing - Investing.com
Beyond Air announces $5.0 million private placement priced at-the-market under Nasdaq rules - marketscreener.com
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - 富途资讯
Beyond Air (XAIR) Stock Soars as Company Sells Autism Drug Platform for $32.5 Million - Blockonomi
Is Beyond Air Inc.’s ROIC above industry averageGrowth Stock Opportunities & Small Capital Portfolio Tips - bollywoodhelpline.com
Beyond Air (XAIR) stock whipsaws after NeuroNOS deal — premarket drop follows 150% rally - TechStock²
Beyond Air (XAIR) Stock Soars 150% on $32M NeuroNOS Subsidiary Sale - CoinCentral
XAIR Stock More Than Doubled TodayWhat's Driving The Rally? - Menafn
Beyond Air Announces $5.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - TradingView
XAIR Stock More Than Doubled Today — What’s Driving The Rally? - Asianet Newsable
XAIR stock Beyond Air (NASDAQ) $2.22 intraday 13 Jan 2026: XTL deal lifts volume - Meyka
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS - citybiz
Crypto: XAIR at Critical Level: Why This Week Matters More Than Ever - InteractiveCrypto
Medical Stocks To Watch NowJanuary 13th - MarketBeat
Promising Pharmaceutical Stocks To Add to Your WatchlistJanuary 13th - MarketBeat
Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments - Benzinga
Beyond Air Stock (XAIR) Opinions on NeuroNOS Acquisition Deal - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
XLT Biopharma To Acquire 85% Of Beyond Air Subsidiary NeuroNOS In Autism Therapeutics Push; Stock Up - Nasdaq
XTL Biopharmaceuticals to acquire autism therapeutics firm NeuroNOS - Investing.com
Beyond Air Inc (XAIR) 財務データ
収益
当期純利益
現金流量
EPS
2.37%
0.96%
大文字化:
|
ボリューム (24 時間):